← Eichor
Study identifier: NCT06646172 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy

Condition: Median Sternotomy  ·  Sponsor: Tongji Hospital

PhaseNA
Planned participants38
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

In light of the ongoing controversy surrounding the efficacy of bupivacaine liposomes, our study was designed to investigate, for the first time, the differential postoperative analgesic effects between bupivacaine liposomes combined with bupivacaine hydrochloride and bupivacaine hydrochloride alone in transverse thoracic muscle plane block treatment. The aim is to provide evidence-based medical guidance for drug selection in regional block local anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

Liu Tianzhu, M.D.  ·  13098866448  ·  liutzh@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tianzhu LiuWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06646172